Register on the prognosis of acute symptomatic seizures

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017811

Enrollment

115

Registered

2019-08-13

Start date

2019-09-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40.5

Interventions

Group 1: After an acute symptomatic first seizure, participants will be followed up for 12 months and interviewed regarding seizure relapse, seizure related hospitalisation, antiepileptic medication,

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Acute symptomatic first epileptic seizure

Exclusion criteria

Exclusion criteria: Status epilepticus

Design outcomes

Primary

Measure	Time frame
Occurrence and time point of a first unprovoked epileptic seizure relapse within 12 months after the acute symptomatic first seizure.	—

Secondary

Measure	Time frame
Occurrence and time point of additional acute symptomatic seizures; initiation of an antiepileptic medication; seizure related rehospitalisation; overall functional outcome (Modified Rankin Score).	—

Countries

Germany

Contacts

Public ContactJulia Herzig-Nichtweiß

Charité - Universitätsmedizin Berlin, Klinik für Neurologie

julia.herzig-nichtweiss@charite.de+4930450660057

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 14, 2026